Rinaa S Punglia Selected Research

Biological Products

7/2017	The Impact of Reexcision and Residual Disease on Local Recurrence Following Breast-Conserving Therapy.
1/2017	Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.
3/2015	Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
6/2006	The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rinaa S Punglia Research Topics

Disease

36	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2002
22	Neoplasms (Cancer) 01/2022 - 06/2003
19	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2022 - 02/2012
3	Brain Neoplasms (Brain Tumor) 10/2016 - 02/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016 - 12/2011
3	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 07/2003
2	Necrosis 01/2018 - 03/2013
2	Hodgkin Disease (Hodgkin's Disease) 11/2009 - 09/2006
1	Triple Negative Breast Neoplasms 01/2021
1	Tinnitus 01/2021
1	Neutropenia 01/2021
1	Infections 01/2021
1	Contracture 09/2019
1	Xerostomia 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Dysgeusia (Parageusia) 01/2018
1	Oropharyngeal Neoplasms 01/2018
1	Pain (Aches) 12/2015
1	Mastodynia 12/2015
1	Lung Diseases (Lung Disease) 11/2015
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Margins of Excision 07/2013
1	Lymphedema (Milroy Disease) 02/2013
1	Disease Progression 02/2012
1	Adenocarcinoma 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2009
1	Seminoma 08/2008
1	Carcinoma (Carcinomatosis) 04/2006
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2006

Drug/Important Bio-Agent (IBA)

9	Estrogen ReceptorsIBA 10/2018 - 06/2003
7	Hormones (Hormone)IBA 01/2022 - 08/2005
7	Tamoxifen FDA LinkGeneric 10/2013 - 06/2003
4	Biological ProductsIBA 07/2017 - 06/2006
3	Aromatase InhibitorsIBA 05/2008 - 08/2005
3	Prostate-Specific Antigen (Semenogelase)IBA 11/2007 - 07/2003
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2015 - 06/2006
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2013 - 05/2008
1	GenieIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	beta-Aminoethyl Isothiourea (AET)IBA 01/2018
1	Carisoprodol (Soma)FDA LinkGeneric 12/2015
1	Analgesics (Analgesic Drugs)IBA 12/2015
1	human ERBB2 proteinIBA 03/2015
1	4-hydroxy-N-desmethyltamoxifenIBA 10/2013
1	LipidsIBA 11/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2009

Therapy/Procedure

30	Radiotherapy 07/2022 - 07/2002
20	Segmental Mastectomy (Lumpectomy) 07/2022 - 06/2003
18	Therapeutics 12/2019 - 08/2005
14	Mastectomy (Mammectomy) 07/2022 - 07/2006
2	Drug Therapy (Chemotherapy) 11/2015 - 03/2010
2	Aftercare (After-Treatment) 11/2014 - 09/2006
1	Adjuvant Chemotherapy 08/2020
1	Tissue Expansion Devices (Tissue Expander) 09/2019
1	Gastrostomy 01/2018
1	Proton Therapy 01/2018
1	Prophylactic Mastectomy 07/2017
1	Chemoprevention 07/2017
1	Precision Medicine 10/2013
1	Mammaplasty (Breast Reconstruction) 06/2013
1	Adjuvant Radiotherapy 12/2012
1	Brachytherapy 01/2012
1	Gastrectomy 01/2012
1	Radiofrequency Ablation 12/2011